Method and system for diagnosing alzheimer's disease
AssigneesPanasonic Healthcare Co., Ltd., Shiga University of Medical Science
InventorsTakaomi Fukuhara, Toshifumi Nanjo, Ikuo Tooyama
Life of this patent
Estimating the term…
Abstract
Disclosed herein is a method for diagnosing Alzheimer's disease capable of minimizing invasiveness to reduce the risk of infection. The method for diagnosing Alzheimer's disease includes the steps of: pretreating an intranasal specimen; detecting tau protein or amyloid beta peptide (Aβ) in the pretreated intranasal specimen; comparing a value of the tau protein or the Aβ obtained in the detection step with a predetermined value; and displaying a comparison result obtained in the comparison step.
Claims13
A method for diagnosing Alzheimer's disease comprising the steps of:
- pretreating an intranasal specimen collected from a nasal cavity;
- detecting tau protein or amyloid beta peptide (hereinafter, referred to as Aβ) in the intranasal specimen pretreated in the pretreatment step;
- comparing a value of the tau protein or the Aβ obtained in the detection step with a predetermined value;
- and
- displaying a comparison result obtained in the comparison step.
A method for diagnosing Alzheimer's disease comprising the steps of:
- pretreating an intranasal specimen collected from a nasal cavity;
- detecting tau protein and Aβ in the intranasal specimen pretreated in the pretreatment step;
- comparing values of the tau protein and the Aβ obtained in the detection step with predetermined values, respectively;
- and
- displaying a comparison result obtained in the comparison step.
A system for diagnosing Alzheimer's disease comprising:
- means for detecting tau protein and Aβ in an intranasal specimen collected from a nasal cavity;
- means for comparing values of the tau protein and the Aβ obtained by the detecting means with predetermined values, respectively;
- and
- means for displaying a comparison result obtained by the comparing means.
Dependencies are inferred from the claim text.